0.69
0.69 (-1.48%)
As of Apr 19, 2023
Lannett Co Inc [LCI]
Source:
Company Overview
Lannett Company, Inc. primarily develop, manufacture, market and distribute generic versions of brand pharmaceutical products.
| Country | United States |
| Headquarters | philadelphia, pennsylvania |
| Phone Number | 2153339000 |
| Industry | manufacturing |
| CEO | Timothy C. Crew, |
| Website | www.fda.gov |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $80.5 |
| Operating Profit | $-86.7 |
| Net Income | $-101.5 |
| Net Cash | $-41.3 |
Profit Ratios
| Gross Margin | $15.2 |
| Operating Margin | -107.7 |
| Profit as % of Revenues | 18.8% |
| Profit as % of Assets | -24.8% |
| Profit as % of Stockholder Equity | 24.6% |
Management Effectiveness
| Return on Equity | 24.6% |
| Return on Assets | -30.3% |
| Turnover Ratio | 0.2% |
| EBITA |
Balance Sheet and Cash Flow Measures
| Total Assets | $334.6 |
| Total Liabilities | $746.9 |
| Operating Cash Flow | $-38.4 |
| Investing Cash Flow | $-2.9 |
| Financing Cash Flow | $-0 |
